Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-23

FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for dorzolamide hydrochloride (generic) submitted by Sandoz Inc to support its use as an ophthalmic treatment for loweri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride (dorzolamide hydrochloride)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE (DORZOLAMIDE HYDROCHLORIDE)